Wilex receives takeover offer from dievini
This article was originally published in Scrip
Executive Summary
Wilex has received a mandatory takeover offer from dievini Hopp BioTech, which exceeded the control threshold of 30% of the German biopharmaceutical company's voting rights on 2 June.